NACDS Praises Senate Finance Committee’s Bipartisan Press Toward “Real PBM Reform”
Emphasizes that Congressional action needs to address the needs of Americans on Medicare and Medicaid and their pharmacies, and lauds Committee’s commitment
NACDS Commends House Oversight and Accountability Committee for Continued Push to Stop ‘Pharmaceutical Benefit Manipulation’ by PBM Middlemen
Oversight hearing “will examine pricing tactics deployed by [PBMs] to enrich themselves at the expense of patients across the country”.
Doctors, Media, Employers Fuel PBM Reform Push
Evidence of “pharmaceutical benefit manipulation” is piling up, as the push continues for comprehensive PBM reform at all levels and branches of government.
Tenth Circuit Opinion in PCMA v. Mulready
In an unfortunate – and arguably errant – legal development, the United States Tenth Circuit Court of Appeals on Tuesday issued an unfavorable decision.
Pharmacy Organizations Blast Tenth Circuit Decision Invalidating an Oklahoma Law Regulating PBMs Ruling creates a split in the federal courts that could lead to the Supreme Court
Ruling creates a split in the federal courts that could lead to the Supreme Court.
NACDS Applauds Sen. Crapo’s Bipartisan Approach to Reducing Patients’ Drug Costs and Protecting Their Freedom of Pharmacy Leadership role on a key committee helps to confront “pharmaceutical benefit manipulation” by “PBM” middlemen
Sen. Crapo is leading a press conference in Twin Falls, ID, on addressing PBM practices that have grown increasingly complex and opaque in recent years at the expense of patients and taxpayers.
NACDS Lauds Senate Finance Committee for Bipartisan Efforts to Deliver Real and Comprehensive PBM Reform that is Meaningful for Patients and Pharmacies Looks forward to continuing work with leaders in the U.S. Congress to address the “pharmaceutical benefit manipulation” that harms the most vulnerable in the Medicaid and Medicare programs
NACDS looks forward to continuing work with leaders in the U.S. Congress to address the “pharmaceutical benefit manipulation” that harms the most vulnerable in the Medicaid and Medicare programs.
NACDS to the U.S. Congress: Real PBM Reform Must Include Medicare and Medicaid A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance
A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance.
In Case You Missed It: FTC to PBMs: That Was Then; This is Now
The FTC on Thursday voted, 3-0, “to issue a statement cautioning against reliance on prior advocacy statements and studies related to pharmacy benefit managers (PBM) that no longer reflect current market realities.”
In Case You Missed It: Federal Trade Commission Will Vote on Clarifying That Prior Statements and Studies on PBMs “No Longer Reflect Current Market Realities” FTC: “The statement is a response to PBMs' continued reliance on older FTC advocacy materials”
FTC: “The statement is a response to PBMs' continued reliance on older FTC advocacy materials”
